ServiceNow’s Knowledge 2020 Launches Today, Focusing on New Era of Employee and Customer Workflow Experiences
ServiceNow (NYSE: NOW),the leading digital workflow company that makes work, work better for people, today launched the Knowledge 2020 Digital Experience, the company’s largest Knowledge ever, for its customers, partners and developer community. Knowledge 2020 focuses on the power of ServiceNow’s workflows to accelerate digital transformation, delivering a new era of employee and customer experiences required in a post-COVID world.
“The unprecedented environment we all find ourselves in is showing C-suite business leaders worldwide that work can be done well anywhere, anytime,” said ServiceNow CEO Bill McDermott. “When employees have flexible, agile, modern workflows to do their jobs when, where and how they need to, productivity doesn’t drop, it increases. Engagement improves. Work gets better.
“Likewise, companies see the need for new ways to engage customers and drive fierce loyalty,” McDermott said. “For employees and customers, it’s all about managing great workflows. Because behind every great experience is a great workflow. That’s the power of the Now Platform, enabling the workflows that deliver the employee and customer experiences everyone wants.”
Knowledge 2020 features keynotes on ServiceNow’s IT, Employee and Customer Service workflow products and the Now Platform. With a single data model and architecture, the Now Platform enables organizations to manage complex workflows across systems and functions, and quickly adapt to unexpected needs such as work from home, managing employee furloughs or doing fast hiring and on-boarding. The Now Platform app engine lets organizations quickly create their own custom workflows.
Keynotes include customer examples from companies such as Lowe’s, Delta and American Express Global Business Travel, demonstrating how they are using ServiceNow to create great experiences and unlock productivity. Also featured is the Washington State Department of Health, which used the Now Platform to create a COVID emergency operations app. The app is one of four COVID response apps that ServiceNow is providing at no charge to customers worldwide; the apps have been installed more than 5,000 times.
Knowledge 2020 Digital Experience reimagines ServiceNow’s originally planned in-person event in Orlando, Fla. Knowledge 2020 includes more than 400 hours of content and experiences across six weeks of digital programming beginning May 5. All content was produced in work-from-home environments by the ServiceNow community. Knowledge 2020 Digital Experience delivers the insights needed to help organizations accelerate their digital transformation and deliver the modern experiences that matter most for employees and customers.
As companies transition from traditional workplaces to everyone “work-from-home” to employees can choose to “work from anywhere,” the need for robust enterprise digital workflows is greater than ever. ServiceNow sees how customers who are farther along in their digital transformation are better equipped to manage these rapidly evolving employee and workplace experiences.
“ServiceNow not only delivers organizations solutions to safely manage the return to company workplaces, but also enables the modern enterprise workflows required to create new ways of working. We’re not just helping companies reopen for work, we’re helping our customers reimagine how works gets done,” McDermott said.
For many employees, the traditional office and desktop workspace will become a pre-COVID artifact. For these employees, their workplace is wherever they want or need it to be, on whatever screen and digital device they prefer, desktop, laptop or mobile. Employees will replace their assigned cubicle with their personal choice, deciding for themselves when, where and how they want to work and stay productive.
This agile, more distributed “anywhere, anytime” workplace of the future will transform how companies operate. Managing complex workflows will be critical to providing employees the services and experiences needed to do their jobs seamlessly and efficiently. Examples include:
- Making it easy to accomplish routine business tasks and processes digitally, regardless of where the employee is physically located.
- Seamlessly managing any employee lifecycle event, including on-boarding, transfers, leaves of absence, furloughs and off-boarding.
- Frequent and targeted employee communications by location, function or level to their preferred screen, such as a desktop and laptop browser or native mobile interface.
- Monitoring and managing office space density to ensure the health and safety of employees and visitors. Workplace services is more important than ever.
- Providing easy monitoring and reporting tools when health concerns occur, ensuring companies and employees can keep everyone safe.
ServiceNow’s comprehensive Employee Workflow products enable these and other experiences. Today, ServiceNow announced the expansion of its Employee Workflow capabilities into enterprise workplace services and legal departments. These capabilities will help customers enhance productivity and manage return to workplace efforts during the COVID-19 pandemic. The company also announced it will be releasing Employee Workflow Content Packs to help organizations navigate return to company workplaces, return to work after furlough and mass onboarding.
ServiceNow signed an agreement to acquire the 4Facility assets of App4Mation, a ServiceNow application and implementation services partner, that will strengthen the company’s soon-to-be-released Workplace Service Delivery product.
Participating in Knowledge 2020
To learn about ServiceNow’s employee workflows and more, visit the Knowledge 2020 Digital Experience. Registration and participation are free. Each week through mid-June, new sessions, channels and content will be made available. Each workflow will have a dedicated channel with keynotes, breakouts, demos and live labs. Register and build your personalized agenda for the free digital experience here.
ServiceNow CEO Bill McDermott will deliver a Knowledge 2020 keynote presentation on June 3. He will be joined by ServiceNow Chief Product Officer CJ Desai and Global Head of Design Amy Lokey. Their keynotes, featuring customer examples, will provide deeper insight into ServiceNow’s purpose to make the world of work, work better for people and into the company’s product and innovation road map.
ServiceNow (NYSE: NOW) is making the world of work, work better for people. Our cloud‑based platform and solutions deliver digital workflows that create great experiences and unlock productivity for employees and the enterprise. For more information, visit: www.servicenow.com.
© 2020 ServiceNow, Inc. All rights reserved. ServiceNow, the ServiceNow logo, Now, and other ServiceNow marks are trademarks and/or registered trademarks of ServiceNow, Inc. in the United States and/or other countries. Other company names, product names, and logos may be trademarks of the respective companies with which they are associated.
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Data from the APOLLO Study Show Clinically Meaningful Response with DARZALEX ® ▼ (daratumumab) Subcutaneous Formulation Regimen After First or Subsequent Relapse in Multiple Myeloma4.12.2020 20:52:00 CET | Press release
The Janssen Pharmaceutical Companies of Johnson & Johnson announced results of the Phase 3 APOLLO study showing that the addition of DARZALEX®▼ (daratumumab) subcutaneous (SC) formulation to pomalidomide and dexamethasone (D-Pd) significantly reduced the risk of progression or death by 37 percent, compared to Pd alone in patients with multiple myeloma (MM) after the first or subsequent relapse of disease.1 The APOLLO results, which will be presented on Sunday, December 6 at 9:00 p.m. CET during the American Society of Hematology (ASH) 2020 Annual Meeting and featured in the ASH press briefing (Abstract #112), add to the body of evidence supporting treatment with daratumumab SC-based regimens for patients with relapsed MM. These data were the basis for recent regulatory submissions in Europe and the United States (U.S.) seeking approval for daratumumab SC in combination with Pd for the treatment of patients with relapsed or refractory MM, with two or more prior lines of therapy, includi
Citi Private Bank Issues Outlook 2021: The New Economic Cycle: Investing for a Post-COVID World4.12.2020 17:36:00 CET | Press release
Citi Private Bank has released its Outlook 2021: The New Economic Cycle: Investing for a Post-COVID World. The twice-yearly publication provides in-depth insights into the global economy and financial markets for the coming year and highlights multi-year “unstoppable trends” for client portfolios. This edition outlines why this is a remarkable time to be an investor. Just as the pandemic changed the price of every security when it arrived, the departure of COVID will mark the beginning of a new economic cycle, creating new opportunities for investors. Citi Private Bank expects 2021 will benefit from an economy that demonstrated resilience in the face of the worst global healthcare crisis in more than a century. 2020 was an opportunity for the world to “test drive the future” and make way for growth as the pandemic ebbs. The tailwinds for 2021 are underappreciated: our financial system is strong, government actions to protect individuals and businesses have been effective, technological
Takashi Nagao Appointed President and Chief Executive Officer of Medicago4.12.2020 17:00:00 CET | Press release
Medicago, a biopharmaceutical company headquartered in Quebec City, Canada, today announced Takashi Nagao as the company’s new President and Chief Executive Officer. Prior to becoming President and CEO, Mr. Nagao served as the Chairman of the Board of Medicago, where for the last four years, he has guided Medicago executives to get the company to where it is today. Medicago, a research and development company for the last 20 years, is embarking on a transformative year, one that will see the company build on its R&D roots to become a company that also produces and commercializes vaccines and other immunotherapies. Mr. Nagao has extensive experience leading pharmaceutical companies through the pre-commercial and commercial process and is well positioned to ensure the successful launch of Medicago’s COVID-19 and influenza vaccines, subject to regulatory approvals. Mr. Nagao will continue Medicago’s evolution towards its goal of being a fully operational commercial entity, able to respond
WorldRemit Leads the Way Offering a USD Payout Option in Nigeria4.12.2020 16:46:00 CET | Press release
WorldRemit, a leading digital cross-border payments business has announced that its customers in Nigeria can now receive remittances in foreign currency (USD) through its cash pick up providers. Following the announcement of the Central Bank of Nigeria (CBN) a day before, WorldRemit quickly adapted to the new requirements making it the first digital service to offer its customers worldwide the option of cash pickup in USD in Nigeria. WorldRemit enables Nigerians in over 50 countries around the world to support their family and friends in Nigeria. The decision by the Central Bank of Nigeria (CBN) to allow international money transfers to be paid in foreign currency, is aimed at providing increased liquidity in the foreign exchange market. The bank explained that the new regulation is part of its efforts to liberalize, simplify and improve the receipt and administration of diaspora remittances into Nigeria. Gbenga Okejimi, Country Manager, Nigeria and Ghana, at WorldRemit, said:“ We are
PPC Upgraded to ‘B’ with ‘Stable’ Outlook by S&P4.12.2020 15:16:00 CET | Press release
In its annual research update released on 27 November 2020, S&P upgraded PPC’s stand-alone credit profile (SACP) upward by two notches to ‘B’ from ‘CCC+’, resulting in an overall upgrade of the long-term credit rating of PPC to ‘B’ from ‘B-‘. According to S&P the two notch upgrade in PPC’s standalone corporate rating confirms that the Company’s strategic repositioning and the improved Greek energy market fundamentals have transformed its competitive position, reducing past concerns over its liquidity and long-term sustainability. The ‘Stable’ outlook underscores S&P’s expectation that PPC will continue to deliver on its transformation plan, with solid liquidity and improved margins. PPC’s strategic plan to convert its generation mix toward lower carbon dioxide (CO2) emissions improve its fleet competitiveness and long-term prospects. As mentioned in their report, S&P expects a substantial increase in EBITDA and improvement in credit metrics on the back of higher profitability as PPC ac
Chengdu Launches Online Exhibition of History and Culture to Enhance Cultural Ties With European Countries4.12.2020 13:17:00 CET | Press release
The launching ceremony of Chengdu History and Culture Overseas Virtual Exhibition was held by the Chengdu Chronicles Compilation Committee at Chengdu Chronicles Office on 24 November. The event, along with the unveiling ceremony of Chengdu Chronicles Culture Overseas (Europe) Exchange Cooperation, were witnessed by distinguished guests in many European countries including the Netherlands, Germany and Belgium through video and online connections. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201204005278/en/ On November 24, Gao Zhigang (center), Director of Chengdu Chronicles Compilation Committee at Chengdu Chronicles Office, and other guests attend the launching ceremony of Chengdu History and Culture Overseas Virtual Exhibition. (Photo: Business Wire) Chengdu History and Culture Overseas Virtual Exhibition will also be launched at major foreign media platforms for audiences all over the world. Gao ZhiGang, Director of Che
New Phase 3 Data Show TAK-620 (maribavir), an Investigational Drug for the Treatment of Transplant Recipients with Refractory/Resistant Cytomegalovirus (CMV) Infections, Meets Primary Endpoint4.12.2020 12:00:00 CET | Press release
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced top-line results from the Phase 3 clinical trial evaluating the efficacy and safety of the investigational drug TAK-620 (maribavir), in the treatment of transplant recipients with refractory/resistant cytomegalovirus (CMV) infection. The TAK-620-303 (SOLSTICE) trial (NCT02931539) is a multicenter, randomized, open-label, active-controlled trial comparing eight weeks of treatment with either maribavir or investigator assigned treatment (IAT) in transplant recipients with CMV infection refractory or resistant to existing antiviral treatments (i.e., one or a combination of ganciclovir, valganciclovir, foscarnet or cidofovir). The SOLSTICE trial met its primary endpoint, defined as the proportion of patients who achieved confirmed CMV viremia clearance compared to IAT at the end of Study week 8. In addition, the SOLSTICE trial met its key secondary endpoint, defined as achievement of CMV viremia clearance
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom